We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Celgene and Novartis filed suit last month after receiving notice that Barr Laboratories submitted an abbreviated new drug application (ANDA) with Paragraph IV certifications for generic Ritalin LA.